Varicella Zoster Virus Infection Clinical Trial
Official title:
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of VZV and HSV Infections in Children, Phase I (VALID-I)
A new paediatric formulation (oral liquid) has been developed for flexible and accurate dosing of valacyclovir in children. To establish the bioavailability of this new formulation, healthy volunteers will be exposed to the new formulation and to valacyclovir tablets. The concentration of valacyclovir in their blood after exposure to the oral liquid will be measured and compared to the tablet.
Bioequivalence of the new valcyclovir formulation will be tested according to the EMA guideline for bioequivalence. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01682109 -
Palatability Testing of a New Paediatric Formulation of Valacyclovir
|
Phase 4 | |
| Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
| Not yet recruiting |
NCT06409494 -
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
|
Phase 1 | |
| Recruiting |
NCT05604911 -
Herpes Virus Infections in Kidney Transplant Patients
|
||
| Recruiting |
NCT05532540 -
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
|
||
| Not yet recruiting |
NCT05664152 -
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
|
N/A | |
| Terminated |
NCT04081480 -
Pharmacokinetics of Valacyclovir Oral Solution in Children
|
N/A | |
| Recruiting |
NCT04403139 -
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
|
Phase 4 |